Is BridgeBio Pharma (BBIO) Stock Worth the Hype?
Автор: The Motley Fool
Загружено: 2025-03-03
Просмотров: 985
Описание:
Join Anand Chokkavelu, Keith Speights, and Karl Thiel as they evaluate BridgeBio Pharma (BBIO) in this episode of Motley Fool Scoreboard. Discover their ratings, insights on the company's business model, management, financials, and stock valuation. Is BBIO a hidden gem in the biopharma sector? Watch now!
------------------------------------------------------------------------
This video is brought to you by The Motley Fool.
Visit https://fool.com/Invest to get access to this special offer. The Motley Fool Stock Advisor returns are 905% as of 2/25/2025 and measured against the S&P 500 returns of 174% as of 2/25/2025. Past performance is not an indicator of future results. All investing involves a risk of loss. Individual investment results may vary, not all Motley Fool Stock Advisor picks have performed as well.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
